About Us

Providing the World With Quality Affordable Healthcare Products®

Headquartered in Ireland, Perrigo Company plc is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products and receives royalties from Multiple Sclerosis drug Tysabri®.

At Perrigo, our mission is clear, "Quality Affordable Healthcare Products®". An essential part of that mission, of course, is quality.

"Quality" is more than a concept at Perrigo, it is our most important priority. That is why we continually invest our time and resources in the quest to achieve ever higher levels of quality execution and quality products - for you, our own family members and everyone who uses our products.

Consumer Healthcare:
Delivering healthcare value on the retail shelf

Our Consumer Healthcare operation includes the company's U.S., U.K. and Mexico manufacturing operations supporting the sale of OTC pharmaceutical products. Our store-brand products contain the same active ingredients as the advertised brands for less cost to the consumer. With store brands, each retailer sells products under its store or another chosen brand name.

Perrigo offers a broad line of high-quality products comparable in quality and efficacy to such advertised brand products as Tylenol®, Advil® or One-A-Day®. For example, Tylenol® has acetaminophen as an active ingredient and is available in stores' analgesic (pain reliever) aisle. Store-brand acetaminophen is located next to the national brand, offering the same active ingredient (acetaminophen) and the same pain relief.

Prescription (Rx) Pharmaceuticals:
Delivering healthcare value across the pharmacy counter

Our Rx Pharmaceuticals business is focused on the development, manufacture and sale of generic prescription drug products, primarily for the U.S. market. Manufacturing operations are based in the U.S. and Israel.

An industry leader in generic Rx technologies, Perrigo's portfolio strategically focuses on complex, high-barrier ophthalmological, topical foam and oral liquid formulations.

Nutritionals:
Leading the way in store brand infant formula

Perrigo Nutritionals manufactures infant formula, pediatric nutritionals and vitamins, minerals, and supplements for the store brand market.

Acquired by Perrigo, PBM Products, LLC, was the first company to introduce private-label, or store-brand infant formulas to the U.S. PBM, now Perrigo Nutritionals, is the largest supplier of store-brand infant formulas and nutrition products in the world. With distribution to major retailers, Perrigo Nutritional products can be found in more than 40,000 retail locations around the world.

Active Pharmaceutical Ingredients (API):
The key to product quality and consistency

Primarily through our Israel-based business, Perrigo develops, manufactures and markets the complex chemicals and active pharmaceutical ingredients used worldwide by the generic drug industry. Certain of these ingredients are also used in Perrigo's own pharmaceutical products. We manufacture API at facilities in Israel, India and China.

Specialty Sciences

With the acquisition of Elan, Perrigo benefits from the royalty stream provided by the Multiple Sclerosis drug Tysabri®.

Pharmaceutical and Medical Diagnostic Products (PDI):
Maintaining strong distribution partnerships in Israel

Through our Israel-based business, Perrigo markets and manufactures branded prescription drugs and medical diagnostic products through exclusive agreements with leading pharmaceutical companies.

Our Pharmaceutical and Medical Diagnostic Products businesses also market and manufacture branded prescription drugs under licenses. Other pharmaceutical and medical diagnostics products are imported to Israel through exclusive agreements.





Cookie Policy

By using our site you consent to the use of cookies in accordance with the terms of our privacy policy.

Hide this message